Dirk Schnappinger

29PUBLICATIONS
142CO-AUTHORS
Medical mycologyIndustrial biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Medical bacteriologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 14, 2026
Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against Mycobacterium tuberculosis.

|Apr 22, 2026
Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis.

|Apr 20, 2026
Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis.

|Apr 18, 2026
Mycobacterium tuberculosis long-chain fatty acid resistome reveals universal stress protein TB15.3 as essential for infection.

|Apr 07, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation.

Dirk Schnappinger, Steven J Berthel, Helena I M Boshoff

|Apr 01, 2026
A periplasmic protein complex mediates arabinofuranosyltransferase activity and intrinsic drug resistance in Mycobacterium tuberculosis.

Thaís Klevorn, Christopher Brown, Christine D Hardy

Pageof 5

Frequent Collaborators

14 joint publications

Sabine Ehrt

6 joint publications

Helena I M Boshoff

5 joint publications

Laura A T Cleghorn

5 joint publications

Véronique Dartois